Alphatec reported a 6 percent increase in net revenue during the second quarter of 0218 and sees organic growth and product development picking up steam in the second half of the year.
Here are three quotes from Alphatec Executive Chairman and CEO Patrick Miles and President, COO and Director Terry Rich from the second quarter conference call, as transcribed by Seeking Alpha.
TR on how the company is measuring success: "The metrics we believe are most predictive of the long-term health of our core business are demonstrating significant improvement. For example, in the second quarter, we hosted a record number of surgeons through our ATEC experience events, educational programs for visiting surgeons who want to learn more about the new ATEC. Conversions of these new relationships is strong."
PM on the next phase of company transformation: "In the second half of this year, the investments being made to radically advance a distinction in clinical powers of our portfolio will begin to come to fruition. We expect increasing contribution to revenue from our 12 new product alpha launches that uniquely address a broad range of surgical procedures."
PM on the approaching NASS annual meeting: "NASS as a demarcation unto itself is not a huge deal. As it relates to NASS, having been here a year, we're making a hell of a lot of progress and we are getting the type of people that we need to ultimately build long-term value…The demographics of this marketplace are such that I think that nimble small companies that created innovative technology are in high demand."